Tekmira Pharmaceuticals (TKMR), which is working to develop an Ebola vaccine, is up 32% in pre-market hours at $27.50 on reports that the first case of the disease has been diagnosed in the U.S. As it has been already reported, the first U.S. Ebola case was confirmed by The Centers for Disease Control, which said […]
View the full post at: Morning Buzz: Tekmira Pharmaceuticals (TKMR), Biocryst Pharmaceuticals (BCRX), Angie’s List Inc (ANGI), Lakeland Industries, Inc. (LAKE)